PELI Logo
title

The MediHerb Prebiotica Regenex Trial

Constipation, the infrequent and hard passage of stools, is often accompanied by symptoms of bloating, discomfort, and pain, and has a negative impact on quality of life. Functional constipation results from the complex interplay between the gastrointestinal tract, the gut microbiome, the nervous system and psychological factors (i.e. anxiety, stress, trauma, and childhood conditioning), along with diet and lifestyle factors (i.e. water intake, exercise, and obesity). Increasing dietary fibre intake is a key recommendation for the management of functional constipation since this promotes bulking of the stool and improves stool transit time.1


The benefits of fibre and polyphenols


Specific plant-based fibres offer additional benefits, supporting metabolic health, exerting antioxidant and anti-inflammatory effects, and modulating the gut microbiota.2 Psyllium,3-5 inulin,6,7 partially hydrolysed guar gum (PHGG),8-11 and acacia gum12 are some specific dietary fibres that have been clinically proven to improve functional bowel health. For more than 60 years, pectin has been used in the treatment of functional constipation,13 with more recent evidence supporting its use in high doses to accelerate colon transit time, alleviate clinical symptoms of constipation and increase the population of healthy gut bacteria species.14 A formulation containing slippery elm has been shown to increase bowel movement frequency, and reduce straining, bloating and abdominal pain in those with irritable bowel syndrome-constipation (IBS-C).15


Fruits and vegetables are particularly rich in polyphenols that have a wide range of beneficial antioxidant, anti-inflammatory, antimicrobial, and anticancer activities.16,17 Reviews of preclinical and clinical data of the effect of polyphenols on the gut microbiota attest to their prebiotic status.18,19 Theobroma cacao (Cacao) is particularly interesting in the context of bowel health as it is both a rich source of fibre and flavonoids that modify the inflammatory process and exert a local effect on inflammation within the gastrointestinal tract.20,21 Nutritional analysis of Hylocereus polyrhizus (Red Dragon Fruit) confirms its high nutritional value as it contains dietary fibre, phenolics, and essential vitamins and minerals.22 A clinical trial reports the laxative effect of whole Dragon Fruit.23


Thus, extracts of Cacao and Red Dragon Fruit have been combined with PHGG, acacia gum, pectin, and slippery elm as sources of dietary fibre to create a prebiotic powder formulation (MediHerb Prebiotica Regenex) specifically designed to treat functional constipation by increasing bowel motions and addressing associated gastrointestinal symptoms.


Efficacy of a prebiotic formulation for treatment of functional constipation and associated gastrointestinal symptoms in adults: A randomised controlled trial


Integria Healthcare funded a three-week randomised, controlled clinical trial to assess the effect of MediHerb Prebiotica Regenex versus a minimal-effect capsule on bowel health in heathy adults with low fibre intake (mean 16 g/day) who met the Rome IV criteria for functional constipation. MediHerb Prebiotica Regenex was taken as per product instructions, i.e. 6 g in water twice daily. Sixty-one participants were enrolled into the trial. There were more female participants (n=49) than male (n=12) in the study,1 which is reflective of females being around 85% more likely to have constipation.24 The primary outcome was change in frequency of complete spontaneous bowel movements (CSBM). Secondary outcomes assessed were gastrointestinal symptoms, quality of life and mood using questionnaires. Safety and tolerability were also assessed.


Fifty-eight participants completed the study. Results indicated significant improvements in bowel movements (p<0.001) and stool consistency (p=0.001) in participants taking MediHerb Prebiotica Regenex compared to those taking the capsule. For participants allocated to the MediHerb Prebiotica Regenex group, the number of CSBM gradually increased each week through the trial (see Figure 1), with the average increasing from 2.8 at baseline to 4.9 CSBM/week at the end of the trial. The difference in mean CSBM was statistically significant after the first 7 days. In comparison, the mean in the capsule group remained almost unchanged, i.e., 2.9 at baseline to 3.0 CSBM/week at the end of the trial.


Among those taking the prebiotic powder, 93% (n=26) were classed as responders to treatment, meaning that they reported an increase by at least 1 CSBM/week. There was a wide variation in response to the treatment, with the median response being an increase of 1 CSBM/week (32%) though some participants reported an increase of up to 4 or 5 CSBM/week (see Figure 2). Only two participants (7%) were considered non-responders, defined as having no increase in CSBM/week. For those taking the capsule, most participants (55%) reported no change at end of treatment, with the remainder split between an increase by 1 CSBM/week (24%) and decrease by 1 CSBM/week (21%).


Accompanying this was a significant reduction in overall gastrointestinal symptoms (p<0.001) including abdominal (p<0.001), rectal (p=0.004) and stool (p=0.022) symptoms, such as abdominal symptoms included discomfort, bloating, stomach cramping, painful bowel movements, and straining to pass bowel movements. Scores were indicative of substantial clinical improvement.


Quality of life also significantly improved in the MediHerb Prebiotica Regenex group (p<0.001). There were significant reductions in mean scores for depression, anxiety and stress for participants in the MediHerb Prebiotica Regenex group (all p<0.001), but improvements also occurred in the capsule group. This suggests that improvement in mood during the study that was unrelated to bowel function. Safety assessment showed no difference at baseline or day 21 in either group.


Summary


This clinical study supports the understanding that increasing dietary fibre intake is a key recommendation for the management of functional constipation. When taken for 21 days as directed, MediHerb Prebiotica Regenex could reduce clinical symptoms of functional constipation in individuals with a low dietary fibre intake by increasing the frequency of bowel improvements, softening the stool, reducing associated gastrointestinal symptoms, and improving quality of life.1


Figure 1. Number of Complete Spontaneous Bowel Motions (CSBM) Per Week1



Figure 2. Change in Number of CSBM Per Week1



References


1. Steels E, Erhardt R, Harnett JE, Vigar V, Steadman KJ. Efficacy of a prebiotic formulation for treatment of functional constipation and associated gastrointestinal symptoms in adults: a randomised controlled trial. Adv Integr Med. 2023 May;10(2):43-50. DOI: 10.1016/j.aimed.2023.05.001

2. Naseer M, Poola S, Uraz S, Tahan V. Therapeutic effects of prebiotics on constipation: a schematic review. Curr Clin Pharmacol. 2020;15(3):207-215. DOI: 10.2174/1574884715666200212125035

3. Noureddin S, Mohsen J, Payman A. Effects of psyllium vs. placebo on constipation, weight, glycemia, and lipids: a randomized trial in patients with type 2 diabetes and chronic constipation. Complement Ther Med. 2018 Oct;40:1-7. DOI: 10.1016/j.ctim.2018.07.004

4. Erdogan A, Rao SSC, Thiruvaiyaru D, Lee YY, Coss Adame E, Valestin J, et al. Randomised clinical trial: mixed soluble/insoluble fibre vs. psyllium for chronic constipation. Aliment Pharmacol Ther. 2016 Jul;44(1):35-44. DOI: 10.1111/apt.13647

5. Ashraf W, Park F, Lof J, Quigley EM. Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol Ther. 1995 Dec;9(6):639-647. DOI: 10.1111/j.1365-2036.1995.tb00433.x

6. Micka A, Siepelmeyer A, Holz A, Theis S, Schön C. Effect of consumption of chicory inulin on bowel function in healthy subjects with constipation: a randomized, double-blind, placebo-controlled trial. Int J Food Sci Nutr. 2017 Feb;68(1):82-89. DOI: 10.1080/09637486.2016.1212819

7. Collado Yurrita L, San Mauro Martín I, Ciudad-Cabañas MJ, Calle-Purón ME, Hernández Cabria M. Effectiveness of inulin intake on indicators of chronic constipation; a meta-analysis of controlled randomized clinical trials. Nutr Hosp. 2014 Aug;30(2):244-252. DOI: 10.3305/nh.2014.30.2.7565

8. Vacca L, Proietti S, Bravi D, Radicati FG, Stocchi F. Effectiveness of an herbaceous derivatives, PHGG, plus sodium hyaluronate in the treatment of chronic constipation in patients with Parkinson's disease: a pilot study. Neurol Sci. 2022 Feb;43(2):1055-1059. DOI: 10.1007/s10072-021-05342-8

9. Kapoor MP, Sugita M, Fukuzawa Y, Okubo T. Impact of partially hydrolyzed guar gum (PHGG) on constipation prevention: a systematic review and meta-analysis. J Funct Foods. 2017 Jun;33:52-66. DOI: 10.1016/j.jff.2017.03.028

10. Polymeros D, Beintaris I, Gaglia A, Karamanolis G, Papanikolaou IS, Dimitriadis G, et al. Partially hydrolyzed guar gum accelerates colonic transit time and improves symptoms in adults with chronic constipation. Dig Dis Sci. 2014 Sep;59(9):2207-2214. DOI: 10.1007/s10620-014-3135-1

11. Takahashi H, Wako N, Okubo T, Ishihara N, Yamanaka J, Yamamoto T. Influence of partially hydrolyzed guar gum on constipation in women. J Nutr Sci Vitaminol (Tokyo). 1994 Jun;40(3):251-259. DOI: 10.3177/jnsv.40.251

12. Calame W, Weseler AR, Viebke C, Flynn C, Siemensma AD. Gum arabic establishes prebiotic functionality in healthy human volunteers in a dose-dependent manner. Br J Nutr. 2008 Dec;100(6):1269-1275. DOI: 10.1017/S0007114508981447

13. Weingarten B, Simon M, Zimetbaum M, Weiss J, Smith LW. The use of pectin-cellulose bread as an adjuvant in dietary regulation and treatment of functional constipation. Am J Gastroenterol. 1962 Mar;37:301-310.

14. Xu L, Yu W, Jiang J, Li N. [Clinical benefits after soluble dietary fiber supplementation: a randomized clinical trial in adults with slow-transit constipation]. Zhonghua Yi Xue Za Zhi. 2014 Dec;94(48):3813-3816.

15. Hawrelak JA, Myers SP. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study. J Altern Complement Med. 2010 Oct;16(10):1065-1071. DOI: 10.1089/acm.2009.0090

16. Ray SK, Mukherjee S. Evolving interplay between dietary polyphenols and gut microbiota-an emerging importance in healthcare. Front Nutr. 2021;8:634944. DOI: 10.3389/fnut.2021.634944

17. Coppo E, Marchese A. Antibacterial activity of polyphenols. Curr Pharm Biotechnol. 2014;15(4):380-390. DOI: 10.2174/138920101504140825121142

18. Nazzaro F, Fratianni F, De Feo V, Battistelli A, Da Cruz AG, Coppola R. Polyphenols, the new frontiers of prebiotics. Adv Food Nutr Res. 2020;94:35-89. DOI: 10.1016/bs.afnr.2020.06.002

19. Kumar Singh A, Cabral C, Kumar R, Ganguly R, Kumar Rana H, Gupta A, et al. Beneficial effects of dietary polyphenols on gut microbiota and strategies to improve delivery efficiency. Nutrients. 2019 Sep;11(9):2216. DOI: 10.3390/nu11092216

20. Goya L, Martín MÁ, Sarriá B, Ramos S, Mateos R, Bravo L. Effect of cocoa and its flavonoids on biomarkers of inflammation: studies of cell culture, animals and humans. Nutrients. 2016 Apr;8(4):212. DOI: 10.3390/nu8040212

21. Ramiro-Puig E, Castell M. Cocoa: antioxidant and immunomodulator. Br J Nutr. 2009 Apr;101(7):931-940. DOI: 10.1017/S0007114508169896

22. Arivalagan M, Karunakaran G, Roy TK, Dinsha M, Sindhu BC, Shilpashree VM, et al. Biochemical and nutritional characterization of dragon fruit (Hylocereus species). Food Chem. 2021 Aug;353:129426. DOI: 10.1016/j.foodchem.2021.129426

23. Lim KG, Ling CV. The effect of Hylocereus polyrhizus (red dragon fruit) on whole gut transit time of young Malaysian adults. Malays J Nutr. 2021;27(1):153-158. DOI: 10.31246/mjn-2020-0100

24. Emmett C, Tinkler L, Khan U, Yiannakou Y. PWE-129 gender differences in patients with chronic constipation in a tertiary referral clinic. Gut. 2018 Jun;67(Suppl 1):A212-A212. DOI: 10.1136/gutjnl-2018-BSGAbstracts.423

logo

Your one stop destination for education and clinical tools, driven by our purpose to inspire people to live better lives through natural healthcare.

Customer Care or Clinical Support

1300 654 336

or visit www.myintegria.com

© 2025, Integria is a registered trademark of Integria Healthcare (Australia) Pty Ltd

Terms of Use | Privacy | Policies